Target intelligence / Profile preview

NIMA-related kinase 1 (NEK1) (NEK1)

Target
NEK1
Molecular classification
Serine/threonine kinase, Tyrosine kinase, Enzyme
01

Overview

NIMA-related kinase 1 (NEK1) is a multifunctional serine/threonine and tyrosine kinase that serves as a critical regulator of the cell cycle, DNA damage response (DDR), and ciliary function. It is localized to the centrosome, nucleus, and primary cilium, where it coordinates microtubule stability and nucleocytoplasmic transport. Mutations in the NEK1 gene are strongly associated with several human pathologies, most notably amyotrophic lateral sclerosis (ALS), where it is one of the most common genetic risk factors, accounting for 2-3% of cases. In ALS, loss-of-function variants lead to impaired microtubule homeostasis and the formation of toxic protein aggregates. NEK1 is also implicated in polycystic kidney disease (PKD) and various malignancies, where its role in DNA repair makes it a potential target for sensitizing tumors to radiotherapy or chemotherapy. Current drug discovery efforts focus on small-molecule inhibitors like BSc5367 for cancer research and strategies to stabilize microtubules in neurodegenerative contexts.

Other names
ALS24NY-REN-55SRPS2SRPS2ASRTD6OFD2Never in mitosis A-related kinase 1
02

Mechanism of action

ATP-competitive inhibition of the kinase domain to block phosphorylation of substrates involved in DNA repair and microtubule stability.

03

Biological functions

DNA damage responseCell cycle regulationCiliogenesisMicrotubule homeostasisNucleocytoplasmic transportMeiosis
04

Disease associations

Amyotrophic lateral sclerosisPolycystic kidney diseaseCancerShort-rib thoracic dysplasiaOrofaciodigital syndrome
05

Safety considerations

Increased sensitivity to genotoxic stressPotential for ciliopathy-related side effectsDisruption of normal cell cycle progression
06

Interacting drugs

BSc5367

2 more in the full profile.

07

Biomarkers

NEK1 loss-of-function mutationsArg261His variantTDP-43 protein aggregation

Beyond the preview

Go deeper on NIMA-related kinase 1 (NEK1) (NEK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIMA-related kinase 1 (NEK1) (NEK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call